Chapters

Transcript

Video

ASCO 2023: Glioma Research Presented by Patrick Wen, MD

The first phase 3 clinical trial of a molecularly targeted therapy for low grade IDH-mutant glioma showed positive results and opens the door to new possibilities for patients. 


Published

June 21, 2023

Created by

Dana-Farber

Related Presenters

Patrick Wen, MD

Patrick Wen, MD

Neuro-oncology

Director, Center for Neuro-Oncology

View full profile